Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

NOSTER & Science Microbiome Prize in AAAS

The American Association for the Advancement of Science (AAAS)

No one walks alone. Every human is enveloped by and contains trillions of microorganisms. The past decade’s research has revealed the essential nature of the relationships with these other organisms for healthy development and adult life. Research on the microbiome has blossomed thanks to technological advances in genomics and bioinformatics. Already, many surprising discoveries have been made about the fundamental role the microbiota play in inflammation, cancer, obesity and many other chronic non-communicable diseases that assail humans. The groundwork has been laid for a shift of gear from mapping microbial associations with health and disease states to working out the mechanistic details and the dynamics of the interactions between hosts and their microbiota. This growing field promises to translate fundamental discoveries and help answer questions about healthy human development, metabolism, and immunity.

The NOSTER & Science Microbiome Prize has been established to reward innovative research by young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions.

Grand Prize winner receives:

Each Grand Prize winner will be awarded a cash prize in the amount of US$25,000 and travel and accommodation for the prize ceremony.

The Grand Prize winner will also receive a free five (5) year digital subscription to Science, and will have their winning essay published in Science (print and online).

Runner(s) Up receives:

Each Runner up will receive an award plaque and travel and accommodation for the prize ceremony.

The Runner(s) Up will also receive a free one (1) year digital subscription to Science, and will have their winning essay published in Science online. Maximum number of Runners Up is 2.

All federal, state and local taxes, and any other costs and expenses, associated with the receipt or use of the prize are the sole responsibility of the winner.

About Science/AAAS

The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society and publisher of the journal Science, as well as Science Translational Medicine; Science Signaling; a digital, open-access journal, Science Advances; Science Immunology; and Science Robotics. AAAS was founded in 1848 and includes more than 250 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world. The nonprofit AAAS is open to all and fulfills its mission to “advance science and serve society” through initiatives in science policy, international programs, science education, public engagement and more.

About NOSTER

Noster was incorporated on May 15, 2020, in Kyoto, Japan, specializing in the research and development of gut microbiome–based treatments with the vision of “connecting life and gut microbiome.” The company’s mission is to elucidate the functions of over 1,000 species of human gut microorganisms—numbering over 100 trillion—that exist symbiotically with humans, and to contribute to scientific advances in microbiotics to improve the health of people worldwide. Recent research shows that immune and digestive diseases as well as certain cancers are linked to the gut microbiome, making it an obvious target for the development of new biotherapy treatments based on manipulating the abundance and biology of gut microorganisms. To solidify its future, Noster is exploiting its deep understanding of the gut microbiome by building a unique library of intestinal microbes and their metabolites, referred to as “postbiotics.” Using this library, company scientists are working passionately to realize breakthroughs in drug discovery and to develop innovative therapeutic treatments targeting the gut microbiome.

Submission

The Prize will be judged on the basis of 1,000-word essay and supporting documents. The essay should describe the innovative research performed by the applicant that reveals exciting novel functions of the microbiota that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions.

The Application period is October 15, 2024 through February 14, 2025.

Procedures for Entry

The entrant must submit the following items:

A completed Entry Form.
An essay, written by the entrant, submitted in Microsoft Word (.doc/.docx), that describes his or her research and places it in perspective in respect to current research in the field of the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions. The essay must not exceed 1,000 words in length. The essay may include one summary figure or table and may have up to 15 references cited numerically in the text (not included in word count).
A one-page letter of recommendation from his or her postdoctoral adviser, supervisor, or other senior colleague who is familiar with the entrant's work.
A Curriculum Vitae that includes the following:
1. Full citations of papers that the entrant has published on the research described in the essay
2. Academic and professional awards and honors that the entrant has received; and
3. Relevant professional experience
Copies of two of the entrant's papers that are most relevant to the essay.
The Entry Form and additional submission materials must be submitted electronically through our prize management system.

Below is a timeline for the prize selection process. You will be contacted only if there are additional materials or information needed.

February/March: Compilation and Review of Submissions

April/May: Selection of Prize Winner

July: Announcement of Prize Winner

October: Award Ceremony

Application deadline: February 14, 2025

Judging Procedures

Editors from Science will be responsible for the initial evaluation of the essays. The top 10 percent of the essays will be forwarded to the judging panel. The judging panel will be composed of prominent international researchers in the field of microbiome research. The essays will be rated in two areas: scientific quality and significance, and clarity and style of the writing.

Specialties

Stem Cells

Eligibility Requirements

For 2024, entrants must be early career scientists who hold an M.D., Ph.D., or M.D./Ph.D at the time of entry, and have received their degree in the last 10 years.

While the research may be part of a larger team effort, an eligible entrant must be a single individual and the essay must focus on their contribution. The applicant must have done or directed all of the work and it must have been performed in the last three years.

Text generated from AI, machine learning, or similar algorithmic tools cannot be used to generate or edit the submission nor its accompanying figures, images, or graphics, without explicit permission from the Science editors. Furthermore, prior to publication of the winning entries, winners will be required to sign Science’s License to Publish, wherein the entrant must warrant that they have followed this requirement.

An entrant may not win more than one Science Prize using the same essay or a similar essay on the same research.

Essays on the same research cannot win more than one Science Prize regardless of who the entrant is.

Past winners of a Science Prize cannot be eligible for another Science Prize until at least 5 years have passed since the award.

Sponsor Details

Sponsor Institute/Organizations: The American Association for the Advancement of Science (AAAS)

Sponsor Type:

Address: Science/AAAS 1200 New York Avenue NW Washington, DC 20005 Editorial: 202-326-6550 News: 202-326-6483

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity